28th week of 2016 patent applcation highlights part 9 |
Patent application number | Title | Published |
20160199430 | A Purified Extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma | 2016-07-14 |
20160199431 | Composition with anoxia-tolerant and anti-fatigue effects and use thereof | 2016-07-14 |
20160199432 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION | 2016-07-14 |
20160199433 | Vegetarian Capsules Containing Supercritical Herbal Extracts | 2016-07-14 |
20160199434 | COMPOSITIONS AND METHODS FOR MODULATING DNA METHYLATION | 2016-07-14 |
20160199435 | METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME | 2016-07-14 |
20160199436 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | 2016-07-14 |
20160199437 | THERAPEUTIC COMPOSITIONS INCLUDING IRON CHELATORS AND USES THEREOF | 2016-07-14 |
20160199438 | GIP AND GLP-1 CO-AGONIST COMPOUNDS | 2016-07-14 |
20160199439 | Application of recombinant immunoregulatory protein of ganoderma lucidum in preparation of drug for treating focal cerebral ischemia | 2016-07-14 |
20160199440 | DESIGNED PEPTIDES FOR TIGHT JUNCTION BARRIER MODULATION | 2016-07-14 |
20160199441 | PAN-ANTIVIRAL PEPTIDES FOR PROTEIN KINASE INHIBITION | 2016-07-14 |
20160199442 | Anti- P2X7 Peptides and Epitopes | 2016-07-14 |
20160199443 | POLYPEPTIDE TARGETING TO MITOCHONDRIA | 2016-07-14 |
20160199444 | New Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Various Diseases | 2016-07-14 |
20160199445 | USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES | 2016-07-14 |
20160199446 | CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS | 2016-07-14 |
20160199447 | LIPID NANOPARTICLES FOR WOUND HEALING | 2016-07-14 |
20160199448 | TREATMENT OF MOOD AND STRESS RELATED DISORDERS | 2016-07-14 |
20160199449 | METHOD OF REDUCING ANTIGENIC DRIFT OR REASSORTMENT OF VIRUSES IN A HOST ANIMAL USING ALPHA INTERFERON | 2016-07-14 |
20160199450 | SCAFFOLDS CONTAINING CYTOKINES FOR TISSUE ENGINEERING | 2016-07-14 |
20160199451 | COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE | 2016-07-14 |
20160199452 | Insulin glargine/lixisenatide fixed ratio formulation | 2016-07-14 |
20160199453 | TRANSDERMAL FORMULATIONS | 2016-07-14 |
20160199454 | FACTOR VIII-XTEN FUSIONS AND USES THEREOF | 2016-07-14 |
20160199455 | Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof | 2016-07-14 |
20160199456 | METHOD AND COMPOSITION TO PREVENT OR IMPROVE SYMPTOMS OF MUSCULOSKELETAL DISTRESS DEGENERATION | 2016-07-14 |
20160199457 | MODULATION OF AXON DEGENERATION | 2016-07-14 |
20160199458 | METHODS OF PROMOTING FAT LOSS COMPRISING ADMINISTERING AN ALK7 INHIBITOR | 2016-07-14 |
20160199459 | COMPOSITIONS AND KITS FOR TREATING PRURITUS AND METHODS OF USING THE SAME | 2016-07-14 |
20160199460 | COMPOSITIONS FOR REDUCING THE DELETERIOUS EFFECTS OF STRESS AND AGING | 2016-07-14 |
20160199461 | Treatment of Synucleinopathies | 2016-07-14 |
20160199462 | METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ERBB2 POSITIVE CANCERS | 2016-07-14 |
20160199463 | HDAC2 DEFENDS VASCULAR ENDOTHELIUM FROM INJURY | 2016-07-14 |
20160199464 | ALGINATE AND ALGINATE LYASE COMPOSITIONS AND METHODS OF USE | 2016-07-14 |
20160199465 | Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging | 2016-07-14 |
20160199466 | Methods For Treating Tissue Fibrosis | 2016-07-14 |
20160199467 | REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY | 2016-07-14 |
20160199468 | Inotropic Antibodies and Therapeutic Uses Thereof | 2016-07-14 |
20160199469 | ONCOLOGY VACCINE | 2016-07-14 |
20160199470 | METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS | 2016-07-14 |
20160199471 | VARIABLE EPITOPE LIBRARY COMPOSITIONS AND METHODS OF THERAPEUTIC AND PROPHYLACTIC USE | 2016-07-14 |
20160199472 | HLA-A* 1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | 2016-07-14 |
20160199473 | Mesothelin Vaccines and Model Systems | 2016-07-14 |
20160199474 | INCAPACITATED WHOLE-CELL IMMUNOGENIC BACTERIAL COMPOSITIONS PRODUCED BY RECOMBINANT EXPRESSION | 2016-07-14 |
20160199475 | LIVE-ATTENUATED VACCINE AGAINST PLAGUE | 2016-07-14 |
20160199476 | DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES | 2016-07-14 |
20160199477 | Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use | 2016-07-14 |
20160199478 | ENVELOPED VIRUS VACCINE AND METHOD FOR PRODUCTION | 2016-07-14 |
20160199479 | T cell receptors | 2016-07-14 |
20160199480 | METHOD FOR PREPARING VIROSOMES | 2016-07-14 |
20160199481 | COMPOSITIONS AND METHODS FOR DIRECTED IMMUNOGEN EVOLUTION AND USES THEREOF | 2016-07-14 |
20160199482 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | 2016-07-14 |
20160199483 | RECOMBINANT CDV COMPOSITIONS AND USES THEREOF | 2016-07-14 |
20160199484 | Fowl Adenovirus Vaccine | 2016-07-14 |
20160199485 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | 2016-07-14 |
20160199486 | ARRANGING INTERACTION AND BACK PRESSURE CHAMBERS FOR MICROFLUIDIZATION | 2016-07-14 |
20160199487 | MODULATION OF TUMOR IMMUNITY | 2016-07-14 |
20160199488 | Combination therapy for neoplasia treatment | 2016-07-14 |
20160199489 | Etanercept Formulations Stabilized with Combinations of Sugars and Polyols | 2016-07-14 |
20160199490 | TRANS CAROTENOIDS, THEIR SYNTHESIS, FORMULATION AND USES | 2016-07-14 |
20160199491 | Compounds compositions and methods including thermally labile moieties | 2016-07-14 |
20160199492 | DIFFUSION PIGMENTS IN PHOTOTHERAPY | 2016-07-14 |
20160199493 | TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID | 2016-07-14 |
20160199494 | COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS | 2016-07-14 |
20160199495 | Polymer Compositions in Biomedical Applications | 2016-07-14 |
20160199496 | Stable Aqueous Formulations of Adenovirus Vectors | 2016-07-14 |
20160199497 | Cholesterol Ester-Depleting Nanomedicine for Non-toxic Cancer Chemotherapy | 2016-07-14 |
20160199498 | PEPTIDES FOR ENHANCING TRANSDERMAL DELIVERY | 2016-07-14 |
20160199499 | USES OF PHOSPHOLIPID CONJUGATES OF SYNTHETIC TLR7 AGONISTS | 2016-07-14 |
20160199500 | COMPOSITIONS COMPRISING VITAMIN B12 AND INTRINSIC FACTOR AND METHODS OF USE THEREOF | 2016-07-14 |
20160199501 | FACTOR VIII ZWITTERIONIC POLYMER CONJUGATES | 2016-07-14 |
20160199502 | Graft Copolymer Polyelectrolyte Complexes for Drug Delivery | 2016-07-14 |
20160199503 | MODIFIED BLOOD FACTORS COMPRISING A LOW DEGREE OF WATER SOLUBLE POLYMER | 2016-07-14 |
20160199504 | Development of Novel Macromolecule Transduction Domain with Improved Cell Permeability and Method for Using Same | 2016-07-14 |
20160199505 | PEPTIDES AND PEPTIDE/ACTIVE COMPOUND CONJUGATES FOR RENAL TARGETING | 2016-07-14 |
20160199506 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | 2016-07-14 |
20160199507 | METHODS FOR TREATING CANCER USING AN IMMUNOTOXIN | 2016-07-14 |
20160199508 | ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | 2016-07-14 |
20160199509 | Cancer Treatment Comprising Therapeutics That Bind to Phosphatidylserine | 2016-07-14 |
20160199510 | HETEROARYLENE-BRIDGED BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING | 2016-07-14 |
20160199511 | METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY | 2016-07-14 |
20160199512 | POLYROTAXANE AND MEDICINAL COMPOSITION | 2016-07-14 |
20160199513 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE | 2016-07-14 |
20160199514 | LAPAROSCOPIC SURGERY SOLUTION AND METHOD OF USING THE SAME | 2016-07-14 |
20160199515 | Compositions Comprising Fluorescent Dyes Associated With Viral Components For Nerve Imaging | 2016-07-14 |
20160199516 | METHOD OF PREPARATION OF BIODEGRADABLE NANOPARTICLES WITH RECOGNITION CHARACTERISTICS | 2016-07-14 |
20160199517 | MRI EVALUATION OF HETEROGENEOUS TISSUE | 2016-07-14 |
20160199518 | Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detection | 2016-07-14 |
20160199519 | Multimodal Imaging of Fibrin | 2016-07-14 |
20160199520 | NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF | 2016-07-14 |
20160199521 | HER2 BINDERS | 2016-07-14 |
20160199522 | Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders | 2016-07-14 |
20160199523 | SOLUBLE TCR MOLECULES AND METHODS OF USE | 2016-07-14 |
20160199524 | RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE AGENTS FOR DUAL-MODALITY IMAGING | 2016-07-14 |
20160199525 | AGENT FOR REMOVING MALODOR FROM PAINTING BOOTH, AND METHOD OF REMOVING MALODOR | 2016-07-14 |
20160199526 | OPHTHALMIC SOLUTION | 2016-07-14 |
20160199527 | ABSORBENT ARTICLE | 2016-07-14 |
20160199528 | FEMININE HYGIENE ABSORBENT ARTICLE | 2016-07-14 |
20160199529 | GEL PULVERIZATION DEVICE, METHOD FOR MANUFACTURING POLYACRYLIC ACID (POLYACRYLATE) SUPERABSORBENT POLYMER POWDER, AND SUPERABSORBENT POLYMER POWDER | 2016-07-14 |